These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30117091)

  • 61. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy.
    Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T
    J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212
    [No Abstract]   [Full Text] [Related]  

  • 62. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
    Ajani JA; Komaki R; Putnam JB; Walsh G; Nesbitt J; Pisters PW; Lynch PM; Vaporciyan A; Smythe R; Lahoti S; Raijman I; Swisher S; Martin FD; Roth JA
    Cancer; 2001 Jul; 92(2):279-86. PubMed ID: 11466680
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined-modality therapy for esophageal and gastroesophageal junction cancers.
    Yoon HH; Gibson MK
    Curr Oncol Rep; 2007 May; 9(3):184-92. PubMed ID: 17430689
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
    Briasoulis E; Fatouros M; Roukos DH
    Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
    [No Abstract]   [Full Text] [Related]  

  • 66. High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma.
    Bichev D; Treese C; von Winterfeld M; Breithaupt K; Dogan Y; Schmidt SC; Daum S; Thuss-Patience PC
    Oncology; 2015; 89(2):95-102. PubMed ID: 25823985
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    Gronnier C; Piessen G; Mariette C
    J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. (Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West.
    Wilke H; Lordick F; Meyer HJ; Stahl M
    Dig Surg; 2013; 30(2):112-8. PubMed ID: 23867587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Gabbani M; Grandinetti A; Tomezzoli A; Ruzzenente A; Guglielmi A; de Manzoni G
    Chir Ital; 2005; 57(1):9-14. PubMed ID: 15832733
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Schneider PM; Eshmuminov D; Rordorf T; Vetter D; Veit-Haibach P; Weber A; Bauerfeind P; Samaras P; Lehmann K
    BMC Cancer; 2018 May; 18(1):548. PubMed ID: 29743108
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of Response to Preoperative Chemotherapy Versus Surgery Alone in Gastroesophageal Cancer: Tumor Resectability, Pathologic Results and Post-Operative Complications.
    Kashefi Marandi A; Shojaiefard A; Soroush A; Ghorbani Abdegah A; Jafari M; Khodadost M; Mahmoudzade H
    Asian Pac J Cancer Prev; 2016; 17 Spec No.():231-7. PubMed ID: 27165231
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.
    Horgan AM; Darling G; Wong R; Guindi M; Liu G; Jonker DJ; Lister J; Xu W; MacKay HM; Dinniwell R; Kim J; Pierre A; Shargall Y; Asmis TR; Agboola O; Seely AJ; Ringash J; Wells J; Marginean EC; Haider M; Knox JJ
    Dis Esophagus; 2016 Nov; 29(8):1152-1158. PubMed ID: 26663741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
    Badgwell B; Ajani J; Blum M; Ho L; Fournier K; Chiang YJ; Matamoros A; Das P; Mansfield P
    Ann Surg Oncol; 2016 Jan; 23(1):156-62. PubMed ID: 26059652
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neoadjuvant Radiochemotherapy for Patients with Locally Advanced Esophagogastric Junction Adenocarcinoma.
    Marica CD; Birlă R; Marica R; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2018; 113(2):192-201. PubMed ID: 29733013
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Submucosal tunneling and endoscopic resection of submucosal tumors at the esophagogastric junction.
    Zhou DJ; Dai ZB; Wells MM; Yu DL; Zhang J; Zhang L
    World J Gastroenterol; 2015 Jan; 21(2):578-83. PubMed ID: 25593479
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy.
    Ryan P; McCarthy S; Kelly J; Collins JK; Dunne C; Grogan L; Breathnach O; Shanahan F; Carey PD; Walsh TN; O'Sullivan GC
    J Surg Res; 2004 Mar; 117(1):121-6. PubMed ID: 15013722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A Case of HER2-Positive Siewert Type I Adenocarcinoma of the Esophagogastric Junction Treated via Neoadjuvant Chemotherapy Followed by Radical Resection].
    Nakajima T; Sato T; Kano K; Maezawa Y; Segami K; Fujikawa H; Ikeda K; Yamada T; Ogata T; Cho H; Yoshikawa T
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1240-1242. PubMed ID: 27760947
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Validation of l-Tellurienylalanine as a Phenylalanine Isostere.
    Vurgun N; Nitz M
    Chembiochem; 2020 Apr; 21(8):1136-1139. PubMed ID: 31742805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.